Financials Al-Modawat Specialized Medical Company
Equities
9594
SA161054LT11
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.42 SAR | -0.69% |
|
-4.38% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net sales 1 | 40.84 | 58.57 |
EBITDA 1 | 0.9338 | 13.1 |
EBIT 1 | -0.4767 | 11.55 |
Operating Margin | -1.17% | 19.72% |
Earnings before Tax (EBT) 1 | -0.6936 | 10.61 |
Net income 1 | -2.206 | 10.31 |
Net margin | -5.4% | 17.61% |
EPS | - | 0.5428 |
Free Cash Flow | - | -2.227 |
FCF margin | - | -3.8% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 21/12/23 | 21/12/23 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net Debt 1 | 1.09 | 7.21 |
Net Cash position 1 | - | - |
Leverage (Debt/EBITDA) | 1.167 x | 0.5504 x |
Free Cash Flow | - | -2.23 |
ROE (net income / shareholders' equity) | - | 41% |
ROA (Net income/ Total Assets) | - | 12.7% |
Assets 1 | - | 81.51 |
Book Value Per Share | - | 1.630 |
Cash Flow per Share | - | 0.0700 |
Capex 1 | 4.53 | 2.77 |
Capex / Sales | 11.09% | 4.73% |
Announcement Date | 21/12/23 | 21/12/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.19Cr | |
-32.30% | 1.34TCr | |
+3.98% | 1.17TCr | |
-3.60% | 1.16TCr | |
+7.59% | 1.08TCr | |
+26.91% | 854.58Cr | |
-11.44% | 723.89Cr | |
+7.31% | 684.24Cr | |
+8.77% | 650.35Cr | |
0.00% | 440.3Cr |
- Stock Market
- Equities
- 9594 Stock
- Financials Al-Modawat Specialized Medical Company